Billing and Coding: Guidance for Anti-Inhibitor Coagulant Complex (AICC) National Coverage Determination (NCD) 110.3
National · Effective Oct 1, 2026
1 active Medicare policy lists J7181, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Oct 1, 2026
9 policies from 8 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J7181 |
|---|---|---|
| Corifact (factor XIII concentrate [human]) Tretten (coagulation factor XIII A-subunit [recombinant]) | Nov 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Factor XIII Products Corifact (factor XIII concentrate [human]) Tretten (coagulation factor XIII A-subunit [recombinant]) | Dec 1, 2025 | Prior auth requiredInferred from policy title |
| Policy | Effective | Status of J7181 |
|---|---|---|
| Factor XIII (e.g., Corifact, Tretten) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7181 |
|---|---|---|
| Factor XIII A-Subunit, Recombinant (Tretten); CP.PHAR.222 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7181 |
|---|---|---|
| Hemophilia Products – Congenital Factor XIII A-Subunit Deficiency: Tretten | Jul 13, 2020 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7181 |
|---|---|---|
| Coagulation Factor XIII A-Subunit, recombinant (Tretten) Listed in Moda Health's provider indexes for Oregon, Alaska, Idaho, Texas. The document does not establish the member's state or line of business. | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7181 |
|---|---|---|
| Clotting Factors, Coagulant Blood Products, & Other Hemostatics | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J7181 |
|---|---|---|
| Clotting Factors, Coagulant Blood Products, & Other Hemostatics | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J7181 |
|---|---|---|
| Clotting Factors, Coagulant Blood Products, & Other Hemostatics | Oct 1, 2026 | Covered |